Clinical Trials in New York

Showing 5361-5380 of 22,668 trials

D-serine AudRem: R33 Phase

NCT05046353

Schizophrenia is a major public health problem associated with cognitive deficits, such as short and long term memory, executive functioning, attention and speed of processing that are amongst the strongest predictors of impaired functional outcome. In addition, schizophrenia patients show reduced "plasticity", defined as reduced learning. D-serine is a naturally occurring activator of the N-methyl-d-aspartate-type glutamate receptors (NMDAR) in the brain, and this project will assess the D-serine treatment over 16 weeks of a program designed to measure auditory plasticity.

SchizophreniaSchizo Affective Disorder

New York State Psychiatric Institute60 participantsStarted Dec 2022

New York, New York, United States

COMPLETEDNA< 1 mile

Radiofrequency Ablation of Atrial Fibrillation Under Apnea

NCT04170894

This study seeks to assess the effect of apnea (breath hold) during atrial fibrillation (AF) ablation by having all ablations performed under apnea. By prospectively studying the effects of apnea on AF ablation, the investigators wish to demonstrate its feasibility, safety and impact on patient outcomes. This is a prospective study that includes both an apnea arm and a control arm. The subjects who consent to the apnea arm will undergo an atrial fibrillation ablation with periods of apnea. The subjects who consent to the control arm will agree to have their data from their standard of care atrial fibrillation be collected for comparison.

Atrial Fibrillation

Weill Medical College of Cornell University128 participantsStarted Oct 2020

Bay Shore, New York, United States • Manhasset, New York, United States • New York, New York, United States +3 more locations

D-serine AudRem: R33 Phase

Radiofrequency Ablation of Atrial Fibrillation Under Apnea

Find Trials by Condition in New York

Whole-Body Hyperthermia for Mood and Anxiety Disorders

A Study to Compare the Efficacy and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas

Enhancing Engagement With Digital Mental Health Care

Clinical Significance of Germline BRCA Mutations

Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder

Phase 2 Study of DKN-01 in Colorectal Cancer

A Model for Genetic Susceptibility: Melanoma

A Prospective Cohort Post Market Registry Evaluating Outcomes of Bridge-Enhanced ACL Restoration (BEAR®)

Use of Adenosine to Determine the Electrophysiological Mechanism of Premature Ventricular Contractions

A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

Multicenter Symphony IL-6 Monitoring Sepsis ICU Study

BiOfeedback, Online for Sibilant Treatment

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis

A Study in Adults and Adolescents With Angelman Syndrome (STARS)

A Study of DKN-01 and Lenalidomide/Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation

Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer

A Study to Evaluate the Pharmacokinetics and Safety of INCB054707 in Participants With Normal Hepatic Function and Participants With Hepatic Impairment